- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02846402
Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda (HSPOT)
The Causal Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda
Study Overview
Detailed Description
Although Uganda has a generalized HIV epidemic, with approximately 7.4% of adults aged 15 to 49 living with HIV, the epidemic remains even more highly concentrated in key populations, including female sex workers (FSW). A particular concern for FSW is access to healthcare services, including HIV testing services. FSW face significant barriers to accessing healthcare. In other settings, evidence has suggested that stigma is a significant barrier to FSW seeking HIV testing. It is likely that similar mechanisms exist in Uganda. Evidence from Uganda has indicated that complex multilevel factors, such as stigmatization and harassment, contribute to vulnerability among FSW. User-controlled HIV prevention interventions that lead to empowerment of FSW may therefore be a powerful way to address the HIV epidemic in this key population.
Oral HIV self-testing consists of an oral swab kit that allows individuals to test for HIV in the privacy of their own homes whenever they want. The ease of use of HIV self-testing, that it can be done at any time, and that is completely private may make it an attractive alternative to currently-available HIV testing mechanisms for FSW in Uganda. HIV self-testing has generally been shown to be acceptable in a variety of populations, however evidence related to its uptake and acceptability remain sparse, especially among key populations and in Sub-Saharan Africa. This research will provide rigorous evidence of the uptake and efficacy of HIV self-testing for this population.
HSPOT was designed to determine whether either direct distribution of HIV self-test kits via peer educators or distribution of HIV self-tests via coupons that participants can use to collect kits at collection points such as drug stores or health posts leads to better coverage of HIV testing and better awareness of HIV status. HSPOT is a cluster-randomized trial in which peer educators recruit a small group of FSW participants, and the peer educator group is randomized to one of three study arms: 1) direct distribution of test kits, 2) fixed distribution of test kits, or 3) referral to standard of care HIV testing. The primary outcome is HIV testing in the past month measured at one and four months after the first peer educator visit (when the test kits or coupons are distributed in the intervention arms).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years of age or older on the enrollment visit date
- Reports exchanging sex (vaginal, anal, and/or oral) for money or goods at least once in the past month
- Self-reported HIV negative status and no recent (<3 months) HIV testing OR self-reported HIV unknown status
- Member of the hot spot where recruited for at least one month AND plans on remaining in the area for the next 4 months
- Have never used an oral HIVST kit
- Willing to participate in peer education sessions on a monthly basis over the 4-month study period and to participate in study assessments
- Of sound mind and not under influence of drugs or coercion
Exclusion Criteria:
- Less than 18 years of age on the enrollment date
- Has not exchanged any form of sex in the past one month
- Self-reported to be living with HIV
- Self-reported HIV negative status and reports testing within the last 3 months
- Planning to move out of geographic area within 4 months
- Concurrently participating in another HIV prevention study
- Meets criteria but does not wish to participate
- Not willing or able to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Direct Distribution
The direct distribution arm consists of peer educators directly distributing HIV self-test kits to participants.
Peer educators will briefly describe HIV self-testing to participants but will not provide extensive training on the use of the test kit.
Peer educators also provide referral to existing services for HIV testing.
|
The Oral HIV Self-Test is an in-home test that uses an oral swab to collect samples of oral mucosa that is used to detect the presence of HIV antibodies.
The test is read after 20 minutes by the user.
The test can be done by an individual at any time and place of the user's choosing.
The test is read visually.
Other Names:
|
|
Experimental: Fixed Distribution
The fixed distribution arm consists of peer educators distributing coupons to participants.
The participants can then use the coupon to collect an HIV self-test kit at a participating distribution point, including drug stores, pharmacies, and health posts.
Peer educators will briefly describe HIV self-testing to participants but will not provide extensive training on the use of the test kit.
Peer educators also provide referral to existing services for HIV testing.
|
The Oral HIV Self-Test is an in-home test that uses an oral swab to collect samples of oral mucosa that is used to detect the presence of HIV antibodies.
The test is read after 20 minutes by the user.
The test can be done by an individual at any time and place of the user's choosing.
The test is read visually.
Other Names:
|
|
No Intervention: Referral to Existing Services
Peer educators will not provide HIV self-tests to participants.
Peer educators will only provide referral to existing services for HIV testing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
HIV testing in the previous month
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
HIV testing in the previous month
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
HIV self-test kit use in the two intervention arms
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Knowledge of own HIV status
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
HIV self-test kit use in the two intervention arms
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Linkage to HIV care and confirmatory testing
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Linkage to HIV care and confirmatory testing
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
HIV risk perception and beliefs about acquiring HIV
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
HIV risk perception and beliefs about acquiring HIV
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
HIV disclosure with sexual partners
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
HIV disclosure with sexual partners
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
Condom use with commercial sexual partners since last visit
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Condom use with commercial sexual partners since last visit
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
Condom use with non-commercial sexual partners since last visit
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Condom use with non-commercial sexual partners since last visit
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
Average number of commercial sexual partners
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Average number of commercial sexual partners
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
Average number of non-commercial sexual partners
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Average number of non-commercial sexual partners
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
Intimate partner violence, including sexual, physical, or verbal
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Intimate partner violence, including sexual, physical, or verbal
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
HIV fatalism
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
HIV fatalism
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
Self-reported self-efficacy as measured by the General Self Efficacy Scale
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Self-reported self-efficacy as measured by the General Self Efficacy Scale
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
Female sex worker empowerment as measured by Beattie et al 2014
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
|
Female sex worker empowerment as measured by Beattie et al 2014
Time Frame: Four months from first intervention visit
|
Four months from first intervention visit
|
|
Pre-exposure prophylaxis preferences
Time Frame: One month from first intervention visit
|
One month from first intervention visit
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Katrina Ortblad, MPH, Harvard School of Public Health (HSPH)
- Principal Investigator: Till Barnighausen, MD, ScD, Harvard School of Public Health (HSPH)
Publications and helpful links
General Publications
- Ortblad KF, Chanda MM, Musoke DK, Ngabirano T, Mwale M, Nakitende A, Chongo S, Kamungoma N, Kanchele C, Barnighausen T, Oldenburg CE. Acceptability of HIV self-testing to support pre-exposure prophylaxis among female sex workers in Uganda and Zambia: results from two randomized controlled trials. BMC Infect Dis. 2018 Oct 4;18(1):503. doi: 10.1186/s12879-018-3415-z.
- McMahon SA, Musoke DK, Wachinger J, Nakitende A, Amongin J, Nanyiri E, Turcotte-Tremblay AM, Oldenburg CE, Barnighausen T, Ortblad KF. Unintended uses, meanings, and consequences: HIV self-testing among female sex workers in urban Uganda. AIDS Care. 2021 Oct;33(10):1278-1285. doi: 10.1080/09540121.2020.1837722. Epub 2020 Nov 2.
- Ortblad KF, Kibuuka Musoke D, Ngabirano T, Nakitende A, Taasi G, Barresi LG, Barnighausen T, Oldenburg CE. HIV self-test performance among female sex workers in Kampala, Uganda: a cross-sectional study. BMJ Open. 2018 Nov 8;8(11):e022652. doi: 10.1136/bmjopen-2018-022652.
- Ortblad K, Kibuuka Musoke D, Ngabirano T, Nakitende A, Magoola J, Kayiira P, Taasi G, Barresi LG, Haberer JE, McConnell MA, Oldenburg CE, Barnighausen T. Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial. PLoS Med. 2017 Nov 28;14(11):e1002458. doi: 10.1371/journal.pmed.1002458. eCollection 2017 Nov.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-0885
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infection
-
Federal University of São PauloGilead SciencesCompleted
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
Fundación HuéspedViiV HealthcareNot yet recruitingHIV-1-infectionArgentina, Brazil
-
Fundación HuéspedMSD Pharmaceuticals LLC; Fundacion IDEAANot yet recruiting
-
Henan Genuine Biotech Co., Ltd.Recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
BioNTech SERecruitingHIV -1 InfectionGermany, United States
-
TaiMed Biologics Inc.Active, not recruitingHIV -1 InfectionUnited States
-
University of North Carolina, Chapel HillNot yet recruiting
-
Craig Cohen, MD, MPHNational Institute of Allergy and Infectious Diseases (NIAID); Duke University and other collaboratorsRecruiting
Clinical Trials on Oral HIV Self-Testing
-
Harvard School of Public Health (HSPH)John Snow, Inc.; International Initiative for Impact EvaluationCompleted
-
Harvard School of Public Health (HSPH)University of Heidelberg Medical Center; University of Witwatersrand, South...UnknownHIV Infections | Knowledge, Attitudes, PracticeSouth Africa
-
London School of Hygiene and Tropical MedicineWorld Health Organization; UNITAID; Liverpool School of Tropical MedicineUnknownHIV Infections | HIV/AIDSMalawi
-
University of California, Los AngelesEmory University; BroadReach Healthcare; USAID, South Africa; South African Department...CompletedHIV Infections | HIV Seropositivity | ARTSouth Africa
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHuman Immunodeficiency Virus (HIV) | Acquired Immune Deficiency Syndrome (AIDS)Lesotho
-
University of TorontoCompletedHIV Infections | HIV/AIDS | Knowledge, Attitudes, PracticeCanada
-
Washington University School of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHIV PreventionNigeria
-
Sue NapieralaUniversity of Pennsylvania; University of North Carolina, Chapel Hill; Impact...Recruiting
-
Chinese University of Hong KongRecruiting
-
University of PennsylvaniaCentre for Sexual Health and HIV/AIDS Research ZimbabweCompleted